[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69027220D1 - Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen - Google Patents

Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen

Info

Publication number
DE69027220D1
DE69027220D1 DE69027220T DE69027220T DE69027220D1 DE 69027220 D1 DE69027220 D1 DE 69027220D1 DE 69027220 T DE69027220 T DE 69027220T DE 69027220 T DE69027220 T DE 69027220T DE 69027220 D1 DE69027220 D1 DE 69027220D1
Authority
DE
Germany
Prior art keywords
composition
inflammable
allergic diseases
treating painful
painful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027220T
Other languages
English (en)
Other versions
DE69027220T2 (de
Inventor
Joel E Bernstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cisco LP
Original Assignee
Cisco LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cisco LP filed Critical Cisco LP
Publication of DE69027220D1 publication Critical patent/DE69027220D1/de
Application granted granted Critical
Publication of DE69027220T2 publication Critical patent/DE69027220T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69027220T 1989-12-19 1990-06-28 Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen Expired - Fee Related DE69027220T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/452,476 US5063060A (en) 1989-12-19 1989-12-19 Compositions and method for treating painful, inflammatory or allergic disorders
PCT/US1990/003674 WO1991008738A1 (en) 1989-12-19 1990-06-28 Compositions and method for treating painful, inflammatory or allergic disorders

Publications (2)

Publication Number Publication Date
DE69027220D1 true DE69027220D1 (de) 1996-07-04
DE69027220T2 DE69027220T2 (de) 1997-01-02

Family

ID=23796595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027220T Expired - Fee Related DE69027220T2 (de) 1989-12-19 1990-06-28 Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen

Country Status (13)

Country Link
US (1) US5063060A (de)
EP (1) EP0506658B1 (de)
JP (1) JPH0780761B2 (de)
KR (1) KR950015056B1 (de)
AT (1) ATE138567T1 (de)
AU (1) AU645023B2 (de)
CA (1) CA2070685C (de)
DE (1) DE69027220T2 (de)
DK (1) DK0506658T3 (de)
ES (1) ES2087160T3 (de)
IL (1) IL95820A (de)
RU (1) RU2095060C1 (de)
WO (1) WO1991008738A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648113A4 (de) * 1992-04-23 1996-12-04 Berlex Lab Bioadhaesive feste mineraloelemulsion.
US6063381A (en) * 1993-05-19 2000-05-16 Staggs; Jeff J. Therapeutic uses of pungent botanicals and their related compounds
US6635659B1 (en) * 1995-03-20 2003-10-21 Arrie Kegler Topical formulation for arthritic symptoms treatment
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5840762A (en) * 1996-01-12 1998-11-24 Genderm Corporation Method for the treatment of cardiac arrhythmias and shortening of action potential duration
DE19622271A1 (de) * 1996-06-03 1997-12-04 Basf Ag Chirale Verbindungen
GB9711962D0 (en) * 1997-06-10 1997-08-06 Reckitt & Colmann Prod Ltd Therapeutically active compositions
JP4677063B2 (ja) * 1997-07-18 2011-04-27 帝國製薬株式会社 オランダカラシエキス配合外用製剤
US6284797B1 (en) * 1999-04-12 2001-09-04 Donald A. Rhodes Topical treatment of pain and to promote healing
EP1605956B1 (de) * 2002-12-18 2015-11-11 Centrexion Therapeutics Corporation Verabreichung von capsaicinoiden zur behandlung von arthrose
DE60322436D1 (de) * 2002-12-18 2008-09-04 Algorx Verabreichung von capsaicinoiden
US20040146464A1 (en) * 2003-01-23 2004-07-29 Bernstein Joel E. Compositions and method for daily tooth and gum care
US20050085552A1 (en) * 2003-10-16 2005-04-21 Winston Laboratories, Inc. Method for providing long-lasting pain relief through intrathecal administration of civamide
US7244446B2 (en) * 2003-10-16 2007-07-17 Winston Laboratories, Inc. Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide
EP1772065B1 (de) * 2004-06-15 2012-11-28 Ajinomoto Co., Inc. Capsinoidhaltige getrocknete paprikaschoten und verfahren zu ihrer trocknung
JPWO2007013690A1 (ja) * 2005-07-28 2009-02-12 味の素株式会社 顧客に適する局所塗布剤とサプリメントとを提供する方法
US20090093446A1 (en) * 2007-10-05 2009-04-09 Winston Laboratories, Inc. Method for alleviating keratoconjunctivitis sicca
US20110014269A1 (en) * 2009-07-14 2011-01-20 Winston Laboratories, Inc. Civamide patch for localized post-incisional neuropathic pain
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
US11166925B2 (en) 2018-08-23 2021-11-09 Elorac, Inc. Method for alleviating keratoconjunctivitis sicca

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460602A (en) * 1981-06-30 1984-07-17 The Procter & Gamble Company Urea derivatives
US4546112A (en) * 1981-12-14 1985-10-08 The Procter & Gamble Company Method for preventing or reducing dipilatory irritation
US4536404A (en) * 1983-06-16 1985-08-20 Dermatological Enterprises, Ltd. Method and composition for treating post-herpetic neuralgia
US4493848A (en) * 1983-07-14 1985-01-15 The Procter & Gamble Company Compositions and methods useful for producing analgesia
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4599342A (en) * 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4702916A (en) * 1985-12-03 1987-10-27 Warner-Lambert Company Analgesic stick compositions

Also Published As

Publication number Publication date
EP0506658B1 (de) 1996-05-29
US5063060A (en) 1991-11-05
ES2087160T3 (es) 1996-07-16
KR920703041A (ko) 1992-12-17
EP0506658A4 (en) 1993-03-03
AU6064890A (en) 1991-07-18
AU645023B2 (en) 1994-01-06
CA2070685A1 (en) 1991-06-20
EP0506658A1 (de) 1992-10-07
DK0506658T3 (da) 1996-06-24
CA2070685C (en) 1994-11-01
JPH05504546A (ja) 1993-07-15
IL95820A (en) 1996-08-04
ATE138567T1 (de) 1996-06-15
JPH0780761B2 (ja) 1995-08-30
RU2095060C1 (ru) 1997-11-10
WO1991008738A1 (en) 1991-06-27
KR950015056B1 (ko) 1995-12-21
DE69027220T2 (de) 1997-01-02

Similar Documents

Publication Publication Date Title
DE69027220D1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ATE497778T1 (de) Lactoferrin-zusammensetzungen und verfahren zur behandlung von diabetischen ulcus
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ATE282591T1 (de) Thioharnstoffverbindungen, zusammensetzungen sowie verfahren zur behandlung oder verhütung von entzündlichen erkrankungen und atherosklerose
DE69435243D1 (de) Verwendung vom neurotoxischem Komponent von Botulinum Toxin zur Behandlung von Glattmuskelkrankheiten
DE3382716D1 (de) Verfahren zur Wärmebehandlung von Plasma oder Plasmafraktionen und so erhaltene Zusammensetzungen.
DE3482754D1 (de) Medikament und medikamentoese zusammensetzung zur behandlung und/oder verhinderung von hautkrankheiten, verursacht durch eine entzuendung.
FR2496458B1 (fr) Composition huileuse destinee au traitement des matieres keratiniques et de la peau
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
DE69911919D1 (de) Verfahren zur behandlung von obst und gemüse nach der ernte mit eugenol und/oder isoeugenol
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DE69638281D1 (de) Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
ATE239467T1 (de) Methode zur behandlung oder verhütung von interstitieller blasenentzundung
DE69330172D1 (de) Zusammensetzung für die Behandlung von Fasern, damit behandelte Fasern, und Verfahren zur Behandlung von Fasern mit dieser Zusammensetzung
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE69319341D1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee